Antisynthetase syndrome: Difference between revisions
(→Medical Therapy: Added content) |
No edit summary |
||
Line 113: | Line 113: | ||
==Treatment== | ==Treatment== | ||
===Medical Therapy=== | ===Medical Therapy=== | ||
Various immunosuppressive agents, such as azathioprine, mycophenolate mofetil, and/or tacrolimus, are used in the treatment of antisynthetase syndrome. Additionally, corticosteroids may be added for management of the myositis and pulmonary manifestations of anti-synthetase syndrome. | Various immunosuppressive agents, such as azathioprine, mycophenolate mofetil, and/or tacrolimus, are used in the treatment of antisynthetase syndrome. Additionally, corticosteroids may be added for management of the myositis and pulmonary manifestations of anti-synthetase syndrome. <ref name="pmid27594777">{{cite journal| author=Witt LJ, Curran JJ, Strek ME| title=The Diagnosis and Treatment of Antisynthetase Syndrome. | journal=Clin Pulm Med | year= 2016 | volume= 23 | issue= 5 | pages= 218-226 | pmid=27594777 | doi=10.1097/CPM.0000000000000171 | pmc=5006392 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27594777 }} </ref> | ||
===Surgery=== | ===Surgery=== |
Revision as of 19:37, 22 July 2022
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: M. Hassan, M.B.B.S
Synonyms and keywords:
Overview
Antisynthetase syndrome, an uncommon autoimmune disorder, is characterized by antibodies against aminoacyl-transfer ribonucleic acid synthetases, with various combinations of three cardinal manifestations of interstitial lung disease (ILD), polymyositis, and arthritis. Other features of antisynthetase syndrome may include pyrexia of unknown origin, mechanic's hand (hyperkeratotic skin changes along the lateral surfaces of the digits) and Raynaud's phenomenon. [1] [2]
Till date, nine different anti-aminoacyl t-RNA synthetase (ARS) antibodies have been identified to play a role in the developement of antisynthetase syndrome. [1]
Historical Perspective
In 1990, Marguerie et al and coworkers first described antisynthetase syndrome as a triad of polymyositis, interstitial lung disease (ILD), and the presence of myositis-specific autoantibodies to aminoacyl-transfer ribonucleic acid synthetases. [3]
Classification
Pathophysiology
Causes
Differentiating Antisynthetase syndrome from other Diseases
Antisynthetase syndrome may be misdiagnosed as idiopathic interstitial lung disease (ILD) or inflammatory myopathy. This is due to the rarity and lack of awareness of the disease, as well as due to the lack of
Most cases of AS are either misdiagnosed as idiopathic ILD or inflammatory myopathy not only due to the lack of awareness of the disease entity but also due to the lack of facilities for detection of anti-ARS antibodies.
Epidemiology and Demographics
Age
Gender
Race
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
In 2010, Connors et al proposed a formal criteria for the diagnosis of antisynthetase syndrome. This criteria proposed that all patients must have a presence of an anti-aminoacyl tRNA synthetase antibody in addition to one or more of the following clinical features: mechanic’s hands, Raynaud’s phenomenon, myositis, ILD, arthritis, and/or unexplained fever.
In 2011, Solomon et al proposed alternative criteria, which is more strict. This criteria requires the presence of anti-aminoacyl tRNA synthetase antibody plus two major or one major and two minor criteria.
Major criteria includes: Interstitial Lung Disease (not attributable to another cause), and Polymyositis or dermatomyositis.
Minor criteria includes: arthritis, Raynaud’s phenomenon, and mechanic’s hands. [4]
Connors et al (2010) criteria |
---|
Required: Presence of an anti-aminoacyl tRNA synthetase antibody |
PLUS one or more of the following clinical features:
1) Raynaud’s phenomenon 2) Arthritis 3) Interstitial lung disease 4) Fever (not attributable to another cause) 5) Mechanic’s hands (thickened and cracked skin on hands, particularly at fingertips) |
Solomon et al (2011) criteria |
---|
Required: Presence of anti-aminoacyl tRNA synthetase antibody |
PLUS two major or one major and two minor criteria:
1) Interstitial Lung Disease (not attributable to another cause) 2) Polymyositis or dermatomyositis
1) Arthritis 2) Raynaud’s phenomenon 3) Mechanic’s hands |
Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Various immunosuppressive agents, such as azathioprine, mycophenolate mofetil, and/or tacrolimus, are used in the treatment of antisynthetase syndrome. Additionally, corticosteroids may be added for management of the myositis and pulmonary manifestations of anti-synthetase syndrome. [4]
Surgery
Prevention
References
- ↑ 1.0 1.1 Maturu VN, Lakshman A, Bal A, Dhir V, Sharma A, Garg M; et al. (2016). "Antisynthetase syndrome: An under-recognized cause of interstitial lung disease". Lung India. 33 (1): 20–6. doi:10.4103/0970-2113.173055. PMC 4748659. PMID 26933302.
- ↑ Robinson D, Scholz B (2020). "The antisynthetase syndrome". Proc (Bayl Univ Med Cent). 33 (3): 401–403. doi:10.1080/08998280.2020.1764818. PMC 7340408 Check
|pmc=
value (help). PMID 32675964 Check|pmid=
value (help). - ↑ Devi HG, Pasha MM, Padmaja MS, Halappa S (2016). "Antisynthetase Syndrome: A Rare Cause for ILD". J Clin Diagn Res. 10 (3): OD08–9. doi:10.7860/JCDR/2016/16872.7361. PMC 4843302. PMID 27134916.
- ↑ 4.0 4.1 Witt LJ, Curran JJ, Strek ME (2016). "The Diagnosis and Treatment of Antisynthetase Syndrome". Clin Pulm Med. 23 (5): 218–226. doi:10.1097/CPM.0000000000000171. PMC 5006392. PMID 27594777.